Nuestro grupo organiza más de 3000 Series de conferencias Eventos cada año en EE. UU., Europa y América. Asia con el apoyo de 1.000 sociedades científicas más y publica más de 700 Acceso abierto Revistas que contienen más de 50.000 personalidades eminentes, científicos de renombre como miembros del consejo editorial.
Revistas de acceso abierto que ganan más lectores y citas
700 revistas y 15 000 000 de lectores Cada revista obtiene más de 25 000 lectores
Das RK
Breast cancer remains a significant health challenge affecting millions of women worldwide. Over the years, advances in breast cancer surgery have played a crucial role in improving patient outcomes, empowering healing, and instilling hope. This abstract highlights the key advancements in breast cancer surgery that have contributed to enhanced treatment strategies, increased survival rates, and improved quality of life for breast cancer patients. Firstly, minimally invasive surgical techniques have revolutionized breast cancer surgery. Procedures such as lumpectomy and sentinel lymph node biopsy have replaced more extensive surgeries, minimizing tissue removal and preserving the natural appearance of the breast. These techniques not only reduce physical trauma but also shorten recovery time and enhance cosmetic outcomes, thus positively impacting patients' psychological well-being. Secondly, oncoplastic surgery has emerged as a transformative approach, combining oncological principles with plastic surgery techniques. It allows for the removal of tumors while simultaneously reshaping and reconstructing the breast, resulting in improved symmetry and aesthetic outcomes. This technique offers a sense of wholeness to patients, bolstering their self-esteem and promoting emotional healing during the recovery process. Furthermore, the advent of targeted therapies has revolutionized the management of breast cancer. Neoadjuvant therapy, including chemotherapy, hormone therapy, and targeted therapies, has enabled downstaging of tumors, making breast-conserving surgery feasible for a broader range of patients. Moreover, the development of intraoperative imaging technologies, such as margin assessment tools and fluorescence-guided surgery, has facilitated precise tumor localization and more effective removal, reducing the need for reoperations and improving overall surgical outcomes.Lastly, the utilization of multidisciplinary teams and shared decision-making models has become integral in breast cancer surgery. Close collaboration between surgeons, oncologists, radiologists, and other healthcare professionals ensures comprehensive patient care and individualized treatment plans. Patients are actively involved in decision-making processes, fostering a sense of empowerment and hope by being informed participants in their treatment journey.